Contributors

Richard Aplenc, MD, MS CE • Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Luigi Calzolai, PhD • Medway School of Pharmacy University of Kent, Kent, UK

Vincent Castranova, PhD • The Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute of Occupational Safety and Health, Morgantown, West Virginia, USA

Joseph Ciccolini, PharmD, PhD • Pharmacokinetics—Medical Oncology Université de la Méditerranée, Marseille, France

David G. Covell, PhD • Developmental Therapeutics Program, National Cancer Institute, Frederick, Maryland, USA

Lea Cunningham, MD • Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

M. Eileen Dolan, PhD • Section of Hematology/Oncology University of Chicago, Chicago, Illinois, USA

Jian Gu, PhD • Department of Epidemiology The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA

Nancy L. Guo, PhD • Mary Babb Randolph Cancer Center, Department of Community Medicine, West Virginia University Morgantown, West Virginia, USA

Ruili Huang, PhD • Developmental Therapeutics Program, National Cancer Institute, Frederick, Maryland, USA

Dong Hwan Kim, MD, PhD • Department of Hematology/Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Federico Innocenti, MD, PhD • Department of Medicine, Section of Hematology/ Oncology, University of Chicago, Chicago, Illinois, USA

Yasuhiro Kuramitsu, MD, PhD • Department of Biochemistry and Functional Proteomics, Yamaguchi University, Graduate School of Medicine, Yamaguchi, Japan

Heinz-Josef Lenz, MD, FACP • Division of Medical Oncology, University of Southern California, Norris Comprehensive Cancer Center, Keck School ofMedicine, Los Angeles, California, USA

Teresa Lettieri, PhD • European Commission-DG Joint Research Centre, Institute for Environment and Sustainability Ispra (VA), Italy

Mark R. Litzow, MD • Division of Hematology Research, Mayo Clinic, Rochester, Minnesota, USA

Georg Lurje, MD • Division of Medical Oncology University of Southern California, Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, California, USA

Sharon Marsh, PhD • Washington University, Division of Molecular Oncology, St. Louis, Missouri, USA

Howard L. McLeod, PhD • University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA

Cedric Mercier, MD, PhD • Medical Oncology, Universite de la Mediterranee, Marseille, France

Gerard Milano, PhD • Laboratoire d'Oncopharmacologie, Centre Antoine Lacassagne, Nice, France

Hironobu Minami, MD • Division of Oncology/Hematology National Cancer Center Hospital East, Kashiwa, Japan

Miguel Angel Molina, PhD • Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona (Barcelona), Spain

Kazuyuki Nakamura, PhD • Department of Biochemistry and Functional Proteomics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan

Yasushi Okuno, PharmD • Department of Pharmacolnformatics, Graduate School of Pharmaceutical Sciences, Kyoto University Kyoto, Japan

Yong Qian, PhD • The Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute of Occupational Safety and Health, Morgantown, West Virginia, USA

Jose Luis Ramirez, PhD • Catalan Institute of Oncology,, Hospital Germans Trias i Pujol, Badalona (Barcelona), Spain

Rafael Rosell, MD • Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona (Barcelona), Spain

Kimie Sai, PhD • Division of Biosignaling National Institute of Health Sciences, Tokyo, Japan

Yoshiro Saito, PhD • Division of Biochemistry and Immunochemistry, National Institute of Health Sciences, Tokyo, Japan

Fernanda Salazar, PhD • Catalan Institute of Oncology,, Hospital Germans Trias i Pujol, Badalona (Barcelona), Spain

Mariacarmela Santarpia, MD • Department of Clinical Oncology and Innovative Therapy, University ofMessina, School ofMedicine, Messina, Italy

Jun-iChi Sawada, PhD • Division of Biochemistry and Immunochemistry National Institute of Health Sciences, Tokyo, Japan

Elke Schaeffeler, PhD • Margarete-Fischer-Bosch, Institute of Clinical Pharmacology, Stuttgart, Germany

Matthias Schwab, MD • Department of Clinical Pharmacology, University Hospital Tuebingen, Tubingen, Germany

Jeffrey Settleman, PhD • Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts, USA

Sreenath V. Sharma, PhD • Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts, USA

Xianglin Shi, PhD • The Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute of Occupational Safety and Health, Morgantown, West Virginia, USA

Richard Simon, DSc • Biometric Research Branch, National Cancer Institute, Bethesda, Maryland, USA

Anurag Singh, PhD • Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts, USA

Margaret R. Spitz, MD, MPH • Department of Epidemiology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA

Martin Stanulla, MD, MSc • Pediatric Hematology Oncology, Hannover Medical School, Hannover, Germany

Natalie Stickle, MSc • UHNMicroarray Centre, University Health Network, T. Robert Beamish Family Convergence Centre of Medical Discovery Toronto, Ontario, Canada

Miquel Taron, PhD • Catalan Institute of Oncology,, Hospital Germans Trias i Pujol, Badalona (Barcelona), Spain

Soken Tsuchiya, PharmD • Department of Genomic Drug Discovery Science, Department ofPharmacoInformatics, Graduate School ofPharmaceutical Sciences, Kyoto University Kyoto, Japan

Gozoh Tsujimoto, MD, PhD • Department of Genomic Drug Discovery Science, Graduate School of Pharmaceutical Sciences, Kyoto University Kyoto, Japan

Anders Wallqvist, PhD • Laboratory of Computational Technologies, SAIC-Frederick, Inc., Frederick, Maryland, USA

Neil Winegarden, MSc • UHN Microarray Centre, University Health Network, T. Robert Beamish Family Convergence Centre of Medical Discovery Toronto, Ontario, Canada

Kwong-Kwok Wong, PhD • Department of Gynecologic Oncology The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA

Xifeng Wu, MD, PhD • Department of Epidemiology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA

Tal Zaks, MD, PhD • Translational Medicine-Oncology, GlaxoSmithKline, Collegeville, Pennsylvania, USA

Genomic Experimental Approaches in Oncology

"This page left intentionally blank."

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment